Davidson Harvey Michael's Insider Trades & SAST Disclosures
Davidson Harvey Michael's most recent trade in NewAmsterdam Pharma Company NV was a trade of 670,467 Option (right to buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Davidson Harvey Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Compan... | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 670,467 | 670,467 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Compan... | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 123,529 | 123,529 | - | - | Ordinary Shares | |
| Silence Therapeutics Plc -... | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 48,000 | 48,000 | - | - | Share Option (Right to Buy) | |
| Tenax Therapeutics Inc | Davidson Michael Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| NewAmsterdam Pharma Compan... | Michael Harvey Davidson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Oct 2024 | 15,000 | 85,000 | - | - | Warrant (right to buy) | |
| NewAmsterdam Pharma Compan... | Michael Harvey Davidson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.27 per share. | 20 Aug 2024 | 5,000 | 209,784 | - | 16.3 | 81,350 | Ordinary Shares |
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 47,500 | 47,500 | - | - | Pre-Funded Warrant | |
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 25,000 | 25,000 | - | - | Warrant | |
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 2,500 | 2,881 (0%) | 0% | - | Common Stock | |
| NewAmsterdam Pharma Compan... | Michael Harvey Davidson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.26 per share. | 20 Jun 2024 | 5,000 | 204,784 | - | 17.3 | 86,309 | Ordinary Shares |
| BioAge Labs Inc. | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 33,986 | 33,986 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| NewAmsterdam Pharma Compan... | Davidson Harvey Michael | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 1,039,939 | 1,039,939 | - | - | Option (right to buy) | |
| Lisata Therapeutics Inc | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,430 | 209,753 (1%) | 0% | 0 | Common Stock | |
| Lisata Therapeutics Inc | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 37,735 | 144,323 (1%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges